Entera Bio Announces Collaboration with OPKO Biologics

Entera Bio and OPKO Biologics have joined forces in a research collaboration to advance the development of oral peptide tablet formulations designed to address obesity and intestinal malabsorption syndromes.

Under the terms of agreement, OPKO will provide its exclusive long-acting GLP-2 peptide along with specific analogs of Oxyntomodulin (OXM) to be used in the creation of oral tablet formulations, leveraging Entera's specialised oral delivery technology.

This collaboration with OPKO signifies a significant step in expanding the application of oral delivery technology to encompass a wider range of valuable peptides.

It is challenging to administer peptides orally due to their rapid degradation within the gastrointestinal tract and limited permeability. GLP-2 analogs have demonstrated the ability to enhance nutrient absorption in patients afflicted with short bowel syndrome (SBS) and subsequently reduce their reliance on parenteral support. 

The current FDA-approved GLP-2 analog, Teduglutide, necessitates daily subcutaneous injections. In SBS patients, oral drug delivery is especially problematic, as the absorptive capacity of the intestine is diminished due to its shortened length and reduced functionality.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!